European Radiology:肝脏淋巴系统的影像学解剖及其在全身淋巴疾病中的作用

2022-02-11 shaosai MedSci原创

淋巴系统的主要功能是将蛋白质和液体从细胞间质中移除并将其送回静脉循环的一个过程。肝脏是淋巴液的最大贡献者之一,占胸导管流量的50%,在引起肝脏充血的疾病中,肝脏淋巴液流量将成倍增加。

淋巴系统的主要功能是将蛋白质和液体从细胞间质中移除并将其送回静脉循环的一个过程。肝脏是淋巴液的最大贡献者之一,占胸导管流量的50%,在引起肝脏充血的疾病中,肝脏淋巴液流量成倍增加。

先天性心脏病(CHD)或原发性淋巴系统疾病患者可出现淋巴系统相关的并发症,如蛋白丢失性肠病(PLE)、乳糜胸、乳糜腹水和格鲁布性支气管炎(PB),可导致严重的并发症甚至死亡。随着动态MRI淋巴成像技术的进步,极大地促进了人们对该类疾病的认识及诊断。然而,人类肝脏淋巴循环显示方面的文献十分稀少。最近,平扫MR肝脏淋巴造影作为一种MR新技术,可以无创地进行肝脏淋巴管的显示以及门静脉高压症发生的变化。然而,这种技术只提供了静态的可视化,并没有提供动态的信息,而这些信息对系统性淋巴疾病的干预至关重要。最近,有学者对肝内动态对比增强MR淋巴管成像(IH-DCMRL)进行了研究及探讨。这种技术与传统的肝脏成像相比有几个重要的优势,即三维成像良好的组织对比度以及可提供灌注信息,并能很好地显示远端结构的灌注情况。

近日,发表在European Radiology杂志的一项研究探讨了系统性淋巴病患者的肝脏外淋巴循环的解剖和流动情况为该类疾病的早期诊断及治疗提供了技术支持

项回顾性研究中纳入了本院2014年5月-2019年4月的进行肝内淋巴管造影患者。进行了影像学审查,并对肝脏淋巴连接和流动模式进行了表征。同时回顾了临床数据,并对接受淋巴干预的患者是否有异常的肝脏淋巴管进行了比较。 

在研究期间,共有105名患者接受了肝内淋巴管造影。主要的临床表现包括腹水(19/105)、乳糜胸(27/105)、PB(17/105)和PLE(42/105)。确定了五类肝脏淋巴连接和流动模式(%):正常(25%,26/105)、肝腹膜(12%,13/105)、肝肺(10.5%,11/105)、肝肠(7.5%,8/105)和肝十二指肠(41%,43/105),其中四名患者有一个以上的异常模式。临床表现和影像学类别之间的比较显示,肝腹水(p < .0001)、乳糜胸/PB与肝腹水(p = .01)和PLE与肝十二指肠(p < .001)连接的可能性增加。76名患者进行了淋巴干预,24%的患者正常,76%的患者肝脏淋巴管异常。两组患者的住院时间和死亡率没有差异,但是在肝脏淋巴管异常的组别中,症状缓解的时间延长(p = .006),6个月后症状持续存在(5% vs 44%,p = .002)。 

 

 肝脏淋巴成像与淋巴疾病表现的比较。与腹水、乳糜胸、PB和PLE的表现相比,(a)正常、(b)肝腹膜、(c)肝肺、(d)肝肠、(e)肝十二指肠的成像百分比。

本能研究共确定了五个不同的淋巴系统模式的影像学类别,该模式显示出与系统性淋巴疾病大的相关性。本研究表明异常影像学模式的存在与疾病的发病率增加有关。同时指出如果中心淋巴系统成像正常,所有患有系统性淋巴疾病的患者都应进行肝脏淋巴管的评估

原文出处

Christopher L Smith,Mandi Liu,Madhumitha Saravanan,et al.Liver lymphatic anatomy and role in systemic lymphatic disease.DOI:10.1007/s00330-021-08098-z

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1729345, encodeId=110c1e29345f8, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Sep 24 08:46:37 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980821, encodeId=a99d19808213c, content=<a href='/topic/show?id=cedb65963b1' target=_blank style='color:#2F92EE;'>#淋巴疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65963, encryptionId=cedb65963b1, topicName=淋巴疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f65b226, createdName=circumcision, createdTime=Fri Oct 28 08:46:37 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512336, encodeId=ceeb15123368e, content=<a href='/topic/show?id=c73d6598434' target=_blank style='color:#2F92EE;'>#淋巴系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65984, encryptionId=c73d6598434, topicName=淋巴系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f36a10457757, createdName=ms7514935887898259, createdTime=Sun Feb 13 03:46:37 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192615, encodeId=ed9d1192615b0, content=大流行病,迄今为止,全世界估计有3.19亿例病例和550万例患者死亡。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sat Feb 12 10:26:54 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192457, encodeId=6bc6119245ea4, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Feb 11 21:15:22 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192393, encodeId=45f011923934b, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48795528355, createdName=小音音, createdTime=Fri Feb 11 17:36:24 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-09-24 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1729345, encodeId=110c1e29345f8, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Sep 24 08:46:37 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980821, encodeId=a99d19808213c, content=<a href='/topic/show?id=cedb65963b1' target=_blank style='color:#2F92EE;'>#淋巴疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65963, encryptionId=cedb65963b1, topicName=淋巴疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f65b226, createdName=circumcision, createdTime=Fri Oct 28 08:46:37 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512336, encodeId=ceeb15123368e, content=<a href='/topic/show?id=c73d6598434' target=_blank style='color:#2F92EE;'>#淋巴系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65984, encryptionId=c73d6598434, topicName=淋巴系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f36a10457757, createdName=ms7514935887898259, createdTime=Sun Feb 13 03:46:37 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192615, encodeId=ed9d1192615b0, content=大流行病,迄今为止,全世界估计有3.19亿例病例和550万例患者死亡。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sat Feb 12 10:26:54 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192457, encodeId=6bc6119245ea4, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Feb 11 21:15:22 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192393, encodeId=45f011923934b, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48795528355, createdName=小音音, createdTime=Fri Feb 11 17:36:24 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1729345, encodeId=110c1e29345f8, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Sep 24 08:46:37 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980821, encodeId=a99d19808213c, content=<a href='/topic/show?id=cedb65963b1' target=_blank style='color:#2F92EE;'>#淋巴疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65963, encryptionId=cedb65963b1, topicName=淋巴疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f65b226, createdName=circumcision, createdTime=Fri Oct 28 08:46:37 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512336, encodeId=ceeb15123368e, content=<a href='/topic/show?id=c73d6598434' target=_blank style='color:#2F92EE;'>#淋巴系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65984, encryptionId=c73d6598434, topicName=淋巴系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f36a10457757, createdName=ms7514935887898259, createdTime=Sun Feb 13 03:46:37 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192615, encodeId=ed9d1192615b0, content=大流行病,迄今为止,全世界估计有3.19亿例病例和550万例患者死亡。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sat Feb 12 10:26:54 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192457, encodeId=6bc6119245ea4, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Feb 11 21:15:22 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192393, encodeId=45f011923934b, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48795528355, createdName=小音音, createdTime=Fri Feb 11 17:36:24 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1729345, encodeId=110c1e29345f8, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Sep 24 08:46:37 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980821, encodeId=a99d19808213c, content=<a href='/topic/show?id=cedb65963b1' target=_blank style='color:#2F92EE;'>#淋巴疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65963, encryptionId=cedb65963b1, topicName=淋巴疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f65b226, createdName=circumcision, createdTime=Fri Oct 28 08:46:37 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512336, encodeId=ceeb15123368e, content=<a href='/topic/show?id=c73d6598434' target=_blank style='color:#2F92EE;'>#淋巴系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65984, encryptionId=c73d6598434, topicName=淋巴系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f36a10457757, createdName=ms7514935887898259, createdTime=Sun Feb 13 03:46:37 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192615, encodeId=ed9d1192615b0, content=大流行病,迄今为止,全世界估计有3.19亿例病例和550万例患者死亡。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sat Feb 12 10:26:54 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192457, encodeId=6bc6119245ea4, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Feb 11 21:15:22 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192393, encodeId=45f011923934b, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48795528355, createdName=小音音, createdTime=Fri Feb 11 17:36:24 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-02-12 查查佳佳

    大流行病,迄今为止,全世界估计有3.19亿例病例和550万例患者死亡。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1729345, encodeId=110c1e29345f8, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Sep 24 08:46:37 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980821, encodeId=a99d19808213c, content=<a href='/topic/show?id=cedb65963b1' target=_blank style='color:#2F92EE;'>#淋巴疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65963, encryptionId=cedb65963b1, topicName=淋巴疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f65b226, createdName=circumcision, createdTime=Fri Oct 28 08:46:37 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512336, encodeId=ceeb15123368e, content=<a href='/topic/show?id=c73d6598434' target=_blank style='color:#2F92EE;'>#淋巴系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65984, encryptionId=c73d6598434, topicName=淋巴系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f36a10457757, createdName=ms7514935887898259, createdTime=Sun Feb 13 03:46:37 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192615, encodeId=ed9d1192615b0, content=大流行病,迄今为止,全世界估计有3.19亿例病例和550万例患者死亡。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sat Feb 12 10:26:54 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192457, encodeId=6bc6119245ea4, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Feb 11 21:15:22 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192393, encodeId=45f011923934b, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48795528355, createdName=小音音, createdTime=Fri Feb 11 17:36:24 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-02-11 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1729345, encodeId=110c1e29345f8, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Sep 24 08:46:37 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980821, encodeId=a99d19808213c, content=<a href='/topic/show?id=cedb65963b1' target=_blank style='color:#2F92EE;'>#淋巴疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65963, encryptionId=cedb65963b1, topicName=淋巴疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f65b226, createdName=circumcision, createdTime=Fri Oct 28 08:46:37 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512336, encodeId=ceeb15123368e, content=<a href='/topic/show?id=c73d6598434' target=_blank style='color:#2F92EE;'>#淋巴系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65984, encryptionId=c73d6598434, topicName=淋巴系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f36a10457757, createdName=ms7514935887898259, createdTime=Sun Feb 13 03:46:37 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192615, encodeId=ed9d1192615b0, content=大流行病,迄今为止,全世界估计有3.19亿例病例和550万例患者死亡。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sat Feb 12 10:26:54 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192457, encodeId=6bc6119245ea4, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Feb 11 21:15:22 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192393, encodeId=45f011923934b, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48795528355, createdName=小音音, createdTime=Fri Feb 11 17:36:24 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-02-11 小音音

    学习了#学习#

    0